转移性激素敏感前列腺癌的系统疗法:基于随机对照试验的网络元分析
Zhen Kang1,2, Wei Li1,2, Yanhong Yu1,2
1College of Medicine, Kunming University of Science and Technology, Kunming, Yunnan 650000, China.
Journal of oncology
|September 16, 2024
概括
雄激素缺乏治疗加上阿帕胺 (ADT+APA) 在转移性激素敏感前列腺癌 (mHSPC) 中显示出更高的整体存活率 (OS) 和无衰竭存活率 (FFS). 建议ADT+APA作为mHSPC患者的常见治疗方法.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 转移性激素敏感前列腺癌 (mHSPC) 需要有效的治疗策略.
- 对比各种治疗方案对于优化患者的治疗结果至关重要.
研究的目的:
- 进行一个网络元分析,比较mHSPC的不同治疗策略.
- 确定最有效的整体存活率 (OS) 和无故障存活率 (FFS) 的治疗方法.
主要方法:
- 在多个数据库中搜索了mHSPC治疗的随机对照试验 (RCT).
- 从涉及14682名患者的18项RCT中提取了OS和FFS数据.
- 根据患者特征进行网络元分析和子组分析.
主要成果:
- 安卓素缺乏治疗 (ADT) +阿帕胺 (APA) 显示了改善OS (96.2%) 和FFS (68.0%) 的最高概率.
- 亚组分析确定了ADT+恩扎胺 (ENZA) 和ADT+阿比拉酸+普雷迪尼松 (AAP) 作为特定患者群体中OS的主要治疗方法.
- 阿比拉,胺和APA显示出显著的疗效,其中APA显示出最突出的效果.
结论:
- 内分泌疗法包括阿比拉,胺和APA是有效的mHSPC.
- 建议ADT + APA作为mHSPC患者的主要治疗选择,考虑个体临床条件.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334


